Mehmet Cengiz Colak

Mehmet Cengiz Colak

Auto-generated profile, based on publicly available information

Mehmet Cengiz Colak

Faculty of Medicine, Department of Cardiovascular Surgery, Inonu University, Malatya, Türkiye

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 September 2022 in ACS Applied Materials & Interfaces
Verified
Journal Article
Open access
SBSEVGI BALCIOGLU
SEVGI BALCIOGLU
SNSamir Abbas Ali Noma
Samir Abbas Ali Noma
AUAhmet Ulu
Ahmet Ulu
MKMerve Goksin Karaaslan-Tunc
Merve Goksin Karaaslan-Tunc
Onural OzhanOnural Ozhan
Onural Ozhan
BABurhan Ates
Burhan Ates
The use of wire cerclage after sternal closure is the standard method because of its rigidity and strength. Despite this, they have many disadvantages such as tissue trauma, operator-induced failures, and the risk of infection. To avoid complications during sternotomy and promote tissue regeneration, tissue adhesives should be used in post-surgical treatment. Here, we report a highly biocompatible, biomimetic, biodegradable, antibacterial, and UV-curable polyurethane-acrylate (PU-A) tissue adhesive for sternal closure as a supportive to wire cerclage. In the study, PU-As were synthesized with variable biocompatible monomers, such as silk sericin, polyethylene glycol, dopamine, and an aliphatic isocyanate 4,4'-methylenebis(cyclohexyl isocyanate). The highest adhesion strength was found to be 4322 kPa, and the ex vivo compressive test result was determined as 715 kPa. The adhesive was determined to be highly biocompatible (on L-929 cells), biodegradable, and antibacterial (on Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus bacteria). Finally, after opening the sternum of rats, the adhesive was applied to bond the bones and cured with UV for 5 min. According to the results, there was no visible inflammation in the adhesive groups, while some animals had high inflammation in the cyanoacrylate and wire cerclage groups. These results indicate that the adhesive may be suitable for sternal fixation by preventing the disadvantages of the steel wires and promoting tissue healing.

16 October 2025 in The Eurasian Journal of Medicine
Verified
Journal Article
Open access
PDF file
FŞFurkan Şakiroğlu
Furkan Şakiroğlu
Cemil ColakCemil Colak
Cemil Colak
MÇMehmet Cengiz Çolak
Mehmet Cengiz Çolak
Atherosclerotic cardiovascular disease (ASCVD) is one of the leading causes of global morbidity and mortality. The current study provides a systematic review of the use of artificial intelligence (AI) technologies applied to the prediction and management of ASCVD. Traditional risk assessment approaches have their restrictions, leading to a growing preference for AI and machine learning techniques in risk assessment. First, this study tackles the complex pathophysiology of ASCVD and the problems associated with the current diagnosis, followed by an in-depth analysis of the wide variety of AI models that can be applied to electronic health records, medical imaging data, and other biomarkers. Special attention will be paid toward the potential of natural language processing models like bidirectional encoder representations from transformers in predicting risk from textual clinical data, and the overwhelming success of convolutional neural networks such as residual neural network and visual geometry group in plaque-based analysis through imaging modalities. Although the research results show that these models have a lot to offer in the clinical world, the authors also describe some serious disadvantages: data bias, interpretability of the model, and computational needs. It highlights, in particular, the need for multicenter validation studies as well as developing explainable AI techniques. Overall, AI-based approaches may pave the way for a new paradigm in ASCVD management. Nevertheless, deploying these technologies in everyday clinical practice will require overcoming technical, ethical, and regulatory challenges. As such, interdisciplinary collaboration and thorough clinical validation studies are essential for fulfilling the promise of these novel strategies to enhance patient outcomes.Cite this article as: Şakiroğlu F, Çolak C, Çolak MC. Pre-trained artificial intelligence models in the prediction and classification of atherosclerotic cardiovascular disease. Eurasian J Med. 2025, 57(3), 0937, doi:10.5152/eurasianjmed.2025.25937.

5 August 2026 in Scientific Reports
Verified
Journal Article
Open access
PDF file
Onural OzhanOnural Ozhan
Onural Ozhan
HYHuseyin Semih Yalcin
Huseyin Semih Yalcin
MCMehmet Cengiz Colak
Mehmet Cengiz Colak
ZUZeynep Ulutas
Zeynep Ulutas
AYAzibe Yıldız
Azibe Yıldız
HPHakan Parlakpinar
Hakan Parlakpinar
Cisplatin (CIS)-induced cardiotoxicity is an important but underrecognized adverse effect that may limit the clinical use of this widely employed chemotherapeutic agent. Oxidative stress (OS) plays a central role in CIS-related cardiac injury. This study aimed to investigate the potential protective effects of thymoquinone (TQ) against acute CIS-induced cardiotoxicity in rats. Thirty-two male Wistar albino rats were simple randomly divided into four groups: Control, CIS, TQ, and CIS + TQ. Acute cardiotoxicity was induced using a single i.p. dose of CIS (7 mg/kg), while TQ was administered i.p. at 5 mg/kg/day for 3 days; therefore, this protocol did not model chronic or cumulative CIS exposure. Hemodynamic parameters and electrocardiographic recordings were obtained to assess cardiac conduction and rhythm. Serum creatine kinase, troponin, and lactate dehydrogenase levels were measured as markers of myocardial injury. OS parameters in heart tissue were evaluated, and histopathological examination was performed. CIS administration induced significant cardiac injury, evidenced by increased arrhythmia incidence, alterations in QRS duration, elevated serum cardiac biomarkers, enhanced myocardial lipid peroxidation, depletion of antioxidant defenses, and marked histopathological damage. TQ co-administration significantly reduced serum cardiac injury markers, restored myocardial antioxidant status, and ameliorated histopathological alterations, while effects on electrophysiological abnormalities showed only a non-significant descriptive trend. TQ alone did not produce adverse cardiac effects. TQ attenuated biochemical, OS, and histopathological indicators of acute CIS-induced cardiac injury in rats. However, these preclinical findings do not establish therapeutic efficacy, and studies using chronic CIS treatment protocols, tumor-bearing animals, and clinical investigations are required before the potential adjunctive use of TQ can be considered.